| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/13/1998 | CN1038304C Method for prepn. of growth inhibiting compsn. |
| 05/12/1998 | US5750709 Method and apparatus for isolating therapeutic compositions from source materials |
| 05/12/1998 | US5750706 Azepanes and their ring homologues having protein kinase inhibiting activity |
| 05/12/1998 | US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 05/12/1998 | US5750673 Nucleosides with 2'-O-modifications |
| 05/12/1998 | US5750669 Nuclease-stable antiviral agents which can suppress synthesis of antigens and gene expression of proteins |
| 05/12/1998 | US5750654 Leukaemia inhibitory factor |
| 05/12/1998 | US5750573 Guanylhydrazones and their use to treat inflammatory conditions |
| 05/12/1998 | US5750567 Farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
| 05/12/1998 | US5750562 Antitumor agents; water soluble; side effect reduction |
| 05/12/1998 | US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
| 05/12/1998 | US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors |
| 05/12/1998 | US5750515 Cancer metastasis inhibitor |
| 05/12/1998 | US5750499 Antitumor |
| 05/12/1998 | US5750493 Alpha-1-acid glycoprotein binders |
| 05/12/1998 | US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides |
| 05/12/1998 | US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 05/12/1998 | US5750146 Translucent collagen formulations with a cytotoxic drug |
| 05/12/1998 | US5750139 Contained in inner space between impermeable top layer and microporous membrane welded togather |
| 05/12/1998 | US5750119 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/12/1998 | US5750078 Side effect reduction |
| 05/12/1998 | CA2016951C Method for preparation of taxol |
| 05/12/1998 | CA2004861C Dermal uses of non-irritating retinoids |
| 05/07/1998 | WO1998018960A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 05/07/1998 | WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 05/07/1998 | WO1998018945A1 Reagents and methods useful for detecting diseases of the breast |
| 05/07/1998 | WO1998018938A1 Novel human spermidine/spermine n1-acetyltransferase |
| 05/07/1998 | WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | WO1998018823A1 Ice inhibiting peptides |
| 05/07/1998 | WO1998018810A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | WO1998018809A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 05/07/1998 | WO1998018759A1 Vitamin d analogues |
| 05/07/1998 | WO1998018493A2 Conjugates useful in the treatment of prostate cancer |
| 05/07/1998 | WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 05/07/1998 | WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol |
| 05/07/1998 | WO1998018461A1 Integrin antagonists |
| 05/07/1998 | WO1998018460A1 Integrin antagonists |
| 05/07/1998 | WO1998018449A1 Methods of preventing breast cancer |
| 05/07/1998 | WO1998018399A1 Method for improved selectivity in photo-activation of molecular agents |
| 05/07/1998 | WO1998018325A1 Prophylaxis of breast cancer |
| 05/07/1998 | WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 05/07/1998 | WO1998008856A3 Mirror-symmetrical selection and evolution of nucleic acids |
| 05/07/1998 | WO1998007855A3 Secreted proteins and polynucleotides encoding them |
| 05/07/1998 | WO1998006841A3 Two human nsp-like proteins |
| 05/07/1998 | WO1998006746A3 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 05/07/1998 | WO1998004242A3 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 05/07/1998 | WO1998000173A3 Targeted drug delivery using sulfonamide derivatives |
| 05/07/1998 | WO1997046683A3 Polynucleotides encoding secreted proteins |
| 05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2535449A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 05/07/1998 | CA2270373A1 Synergistic composition comprising rapamycin and calcitriol |
| 05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269865A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 05/07/1998 | CA2269738A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | CA2268940A1 Integrin antagonists |
| 05/07/1998 | CA2268738A1 Conjugates useful in the treatment of prostate cancer |
| 05/07/1998 | CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | CA2252783A1 Method for improved selectivity in photo-activation of molecular agents |
| 05/06/1998 | EP0839908A2 A novel human ETS family member, ELF3 |
| 05/06/1998 | EP0839830A1 Polyether nucleic acids |
| 05/06/1998 | EP0839814A2 Indolocarbazole derivatives and their use for the treatment of prostate gland disorders |
| 05/06/1998 | EP0839533A1 Methods of preventing breast cancer by the administration of Raloxifene |
| 05/06/1998 | EP0839532A1 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene |
| 05/06/1998 | EP0839529A2 Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases |
| 05/06/1998 | EP0839207A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 05/06/1998 | EP0839205A1 Liver-specific adenovirus expression vector |
| 05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
| 05/06/1998 | EP0839194A1 Protein p53 variants and their therapeutic uses |
| 05/06/1998 | EP0839191A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 05/06/1998 | EP0839183A1 Immortalized epithelial tumor cell |
| 05/06/1998 | EP0839154A1 Biologically active peptides and compositions, their use |
| 05/06/1998 | EP0839143A1 Tetralin compounds with mdr activity |
| 05/06/1998 | EP0839140A1 Tribenzimidazoles useful as topoisomerase i inhibitors |
| 05/06/1998 | EP0839133A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 05/06/1998 | EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 05/06/1998 | EP0839054A1 Tumor- or cell-specific herpes simplex virus replication |
| 05/06/1998 | EP0839053A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 05/06/1998 | EP0839026A1 Polyether block copolymer micellar compositions for targeting biological agents |
| 05/06/1998 | EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/06/1998 | EP0740652B1 Metalloproteinase inhibitors |
| 05/06/1998 | EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 05/06/1998 | EP0438519B1 Therapeutic peptides |
| 05/06/1998 | CN1181083A Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11| and related compounds |
| 05/06/1998 | CN1181077A Benzopyran-containing compounds and method for their use |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181066A Arylsulfonylamino hydroxamic acid derivatives |
| 05/06/1998 | CN1181018A 多功能酶 Multifunctional enzyme |
| 05/06/1998 | CN1181014A A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 05/06/1998 | CN1181010A A Pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 05/06/1998 | CN1181009A A Pharmaceutical composition N-chlorophenylcarbamates, N-chlorophenylthiocarbamates and N-phosphonoglycine derwatives for inhibiting the growth of cancers and viruses in mammals |
| 05/06/1998 | CN1180711A Thioether conjugates |
| 05/06/1998 | CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family |
| 05/06/1998 | CN1180570A High polymer antineoplastic guide medicine and preparation method thereof |
| 05/06/1998 | CN1180559A Chinese herbs injection for treating oncoma (cancer) and preparation method |
| 05/05/1998 | US5747663 Process for the depletion or removal of endotoxins |